Return on Investment: Open-source Adoption

James Black & Orla Doyle , Ning Leng , Phil Bowsher

2025-09-15

Welcome

ROI for open-source adoption

Why is ROI an important conversation for open-source adoption?

• We work in a high stakes yet risk averse industry.

• Value and impact of open-source is sometimes misunderstood.

• To acquire and / or sustain investment, business critical framing is often needed.

Adoption and ROI on the Rise

Ross Farugia, pharmaverse¹

Vincent Chen, Roche²

Nick Masel, JnJ at posit conf 2024³ James Black at R/Pharma 2024⁴

1. https://phuse.s3.eu-central-1.amazonaws.com/Archive/2024/Connect/EU/Strasbourg/PRE_OS01.pdf

2. https://insightsengineering.github.io/nest-2023-summeR/resources/NEST_%20Now%20&%20Future.pdf

3. https://nicholas-masel.github.io/posit2024/2024_posit_conf.html#/benefits-of-shift-to-shiny

4. https://www.youtube.com/watch?v=TMZNcuvJS-0

Proposal

Whitepaper for ROI

We suggest collaborating on a white paper to consolidate fragmented knowledge on ROI for open-source adoption in clinical trials—creating a shared evidence base for the entire industry.

If you would like to be involved please email: phil@posit.co, james_alexander.black@novartis.com, orla.doyle@novartis.com,

On the shoulders of colleagues

• The PHUSE whitepaper on OS includes notes on the ‘why’
• The PHUSE effort to discuss OS currently has a gap in community engagement
• Numerous talks exist. Check out Phil’s notes.

Let’s hear from you

Wrap up

• How might this type of paper help you?
• Roundtables - let’s continue discussions on ROI
• Volunteers to contribute to the ROI Whitepaper